http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Deborah J. Miller (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
Virtues in Relation to Subjective Well-Being for People With Chronic Illness and Disability
Phillip S. Keck,Deborah J. Miller,Rene Gonzalez,Fong Chan,Norman L. Berven,Jeong Han Kim 한국상담학회 2011 Journal of Asia Pacific counseling Vol.1 No.1
This study examined the strength of two constructs of positive psychology, virtue and character, in relation to subjective wellbeing. The sample consisted of 100 individuals with chronic illnesses and disabilities. Participants were clustered based on their Sense of Well-Being Inventory-Revised subscale scores using Ward`s hierarchical agglomerative clustering method. Three clusters were identified and labeled as high, intermediate, and low well-being. More than half of the participants (n=59) were identified to be in the intermediate well-being cluster, while the remaining participants were identified in the high (n=23) and low (n=18) well-being clusters. Discriminant analysis, followed by univariate analyses of variance, indicated that the three well-being clusters could be differentiated based on the two virtue factors. The participants in the high well-being cluster demonstrated higher practical wisdom and interpersonal harmony scores. Thus, evidence was found to support a relationship between the constructs of virtue and character strength and the subjective well-being of people with disabilities.
-
Can a Point-of-Care Troponin I Assay be as Good as a Central Laboratory Assay? A MIDAS Investigation
W. Frank Peacock,Deborah Diercks,Robert Birkhahn,Adam J. Singer,Judd E. Hollander,Richard Nowak,Basmah Safdar,Chadwick D. Miller,Mary Peberdy,Francis Counselman,Abhinav Chandra,Joshua Kosowsky,James N 대한진단검사의학회 2016 Annals of Laboratory Medicine Vol.36 No.5
Background: We aimed to compare the diagnostic accuracy of the Alere Triage Cardio3 Tropinin I (TnI) assay (Alere, Inc., USA) and the PathFast cTnI-II (Mitsubishi Chemical Medience Corporation, Japan) against the central laboratory assay Singulex Erenna TnI assay (Singulex, USA). Methods: Using the Markers in the Diagnosis of Acute Coronary Syndromes (MIDAS) study population, we evaluated the ability of three different assays to identify patients with acute myocardial infarction (AMI). The MIDAS dataset, described elsewhere, is a prospective multicenter dataset of emergency department (ED) patients with suspected acute coronary syndrome (ACS) and a planned objective myocardial perfusion evaluation. Myocardial infarction (MI) was diagnosed by central adjudication. Results: The C-statistic with 95% confidence intervals (CI) for diagnosing MI by using a common population (n=241) was 0.95 (0.91-0.99), 0.95 (0.91-0.99), and 0.93 (0.89-0.97) for the Triage, Singulex, and PathFast assays, respectively. Of samples with detectable troponin, the absolute values had high Pearson (RP) and Spearman (RS) correlations and were RP =0.94 and RS=0.94 for Triage vs Singulex, RP =0.93 and RS=0.85 for Triage vs PathFast, and RP =0.89 and RS=0.73 for PathFast vs Singulex. Conclusions: In a single comparative population of ED patients with suspected ACS, the Triage Cardio3 TnI, PathFast, and Singulex TnI assays provided similar diagnostic performance for MI.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
